Validity of endocan as a biomarker in systemic sclerosis: relation to pathogenesis and disease activity
Abstract Background Systemic sclerosis (SSc), an autoimmune disease, has endothelial dysfunction and tissue fibrosis. The lack of its specific activity markers urges the research. Endocan is an immunomodulatory protein associated with endothelial dysfunction. We aimed to measure of the endocan level...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-11-01
|
Series: | Egyptian Rheumatology and Rehabilitation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43166-020-00025-2 |